Health & Science

• Saturday, January 29th 2022 - 09:23 UTC

  Brazil's Anvisa outlines differences between pediatric COVID-19 vaccines

  

  Brazil's National Health Surveillance Agency (Anvisa) Friday released a statement warning of the differences between COVID-19 vaccines for children to highlight the specifics of newly-released drugs.

• Saturday, January 29th 2022 - 02:40 UTC

  Biologists to monitor South Atlantic fauna during 2022 Antarctic campaign

  

  The Argentina Navy's icebreaker ARA Almirante Irízar has added four biologists to its crew to monitor wildlife in the South Atlantic and around Antarctica, the news service Télam has reported.

• Friday, January 28th 2022 - 09:22 UTC

  Moderna starts testing HIV vaccine in humans

  

  The Moderna Laboratory has begun the so-called phase 1 trial stage of an HIV vaccine using messenger RNA technology in the United States, on 56 uninfected adults, both the biotech company and the International AIDS Vaccine Initiative (IAVI) announced Thursday.

• Friday, January 28th 2022 - 09:11 UTC

  European agency green-lights Pfizer COVID-19 pill

  

  The European Medicines Agency (EMA) Thursday announced it had approved the use of Pfizer's anti-COVID-19 pill Paxlovid, which has thus become the first oral treatment cleared for use in the European Union. The new drug is a combination of the molecule PF-07321332 and the HIV antiviral Ritonavir.

• Thursday, January 27th 2022 - 09:18 UTC

  Number of COVID-19 cases goes up in the Americas, PAHO says

  

  The Pan American Health Organization (PAHO) said Wednesday that a 32% increase in COVID-19 cases had been reported in the Americas during the past week, which represented around 8 million new infections.

• Wednesday, January 26th 2022 - 20:21 UTC

  COVID-19 hospitalizations pushing Brazil's health system to its limits

  

  Brazil's National Council of Secretaries of Health (Conass) Wednesday reported that intensive care units (ICUs) at eight States were full up to over 80% of their capacity with COVID-19 patients and that the situation was likely to worsen in the coming days.

• Wednesday, January 26th 2022 - 09:55 UTC

  Over 50% of Uruguayans have received a booster dose of vaccine

  

  Uruguay's Presidential Secretary Álvaro Delgado Tuesday encouraged more people to get vaccinated against COVID-19 after the Health Ministry announced 50.08% of the population has already taken a third dose immunizer against the virus.

• Wednesday, January 26th 2022 - 09:47 UTC

  Paraguayan President to skip Prosur Summit due to COVID-19

  

  Paraguay's President Mario Abdo Benítez Tuesday announced he shall not be attending the Forum for the Progress of South America (Prosur) because he continues to be down with COVID-19, but will participate in the event in a virtual manner.

• Wednesday, January 26th 2022 - 09:45 UTC

  No more PCR tests for fully vaccinated Argentines to return

  

  Argentina's health authorities have decided to stop requiring a negative PCR test on national citizens and residents entering the country as of Jan. 29, it was announced Tuesday. Other lighter measures will also become effective that day.

• Wednesday, January 26th 2022 - 09:42 UTC

  Covid-19: 21 million new cases and 50,000 deaths globally in week Jan 17/23

  

  Globally, the number of new COVID-19 cases increased in the past week (17-23 January 2022) by 5%, while the number of new deaths remained similar to that reported during the previous week. Across the six WHO regions, over 21 million new cases were reported this week, representing the highest number of weekly cases recorded since the beginning of the pandemic.